Filing Details
- Accession Number:
- 0000939767-20-000100
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-22 21:11:08
- Reporting Period:
- 2020-05-21
- Accepted Time:
- 2020-05-22 21:11:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202095 | T Vincent Marchesi | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-21 | 7,728 | $0.00 | 90,212 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-05-21 | 40,000 | $5.82 | 130,212 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-21 | 40,000 | $24.64 | 90,212 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Acquisiton | 2020-05-21 | 15,456 | $0.00 | 15,456 | $24.62 |
| Common Stock | Option (right to buy) | Disposition | 2020-05-21 | 40,000 | $0.00 | 40,000 | $5.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,456 | 2020-05-21 | 2027-05-20 | No | 4 | A | Direct |
| 40,004 | 2013-12-06 | 2020-12-05 | No | 4 | M | Direct |
Footnotes
- Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
- The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 21, 2021, subject to the Reporting Person's continuous service through that date.
- Includes 18,045 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.56 to $25.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
- Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date.
- The option, representing the right to purchase a total of 80,004 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013.
Billionaire Hedge Funds
